Savara Preparing Clinical Trial on Lung Infection Therapy for CF After Completing $20M Round of Financing
Cystic Fibrosis, News
Austin, Texas-based Savara Pharmaceuticals, a company focused on novel drugs for the treatment of rare respiratory diseases, recently announced the completion of a $20 million Series C round of financing. The ... Read more